Wave Life Sciences Home
  • About
    • Overview
    • History
    • Leadership
    • Commitment
    • Contact Us
  • Science
    • Overview
    • Platform
    • Collaborations
    • Manufacturing
  • Pipeline
    • Overview
    • Lead programs
  • Careers
    • Overview
    • Working at Wave
    • Opportunities
  • For Patients
  • For the Scientific Community
  • For Investors & Media
  • Contact Us
  • For Patients
  • For the Scientific Community
  • For Investors & Media
  • Wave Life Sciences Twitter
  • Wave Life Sciences LinkedIn
  • Wave Life Sciences Glassdoor
  • Contact Wave Life Sciences
  • Search Wave Life Sciences

    • Overview
    • History
    • Leadership
    • Commitment
    • Contact
    • Overview
    • Platform
    • Collaborations
    • Manufacturing
    • Overview
    • Lead Programs
    • Overview
    • Working at Wave
    • Opportunities
  • Search Wave Life Sciences

Realizing a brighter future
for patients and families

We are a genetic medicines company focused on delivering life-changing treatments for people battling devastating diseases.

Using PRISMTM, our proprietary discovery and drug development platform that enables the precise design, optimization and production of novel, stereopure oligonucleotides, we are developing potential medicines to reduce, restore or modulate proteins responsible for genetic diseases.

Explore our science 

Realizing a brighter future
for patients and families

We are a genetic medicines company focused on delivering life-changing treatments for people battling devastating diseases.

Using PRISMTM, our proprietary discovery and drug development platform that enables the precise design, optimization and production of novel, stereopure oligonucleotides, we are developing potential medicines to reduce, restore or modulate proteins responsible for genetic diseases.

Explore our science

Realizing a brighter future
for patients and families

Jun 14, 2022

Wave Life Sciences Announces Pricing of $70.0 Million Underwritten Offering

May 25, 2022

Wave Life Sciences to Present at the 2022 Jefferies Healthcare Conference

Vast potential impact

We are creating a powerful genetic toolbox with the potential to impact many serious conditions for which there are currently few or no treatment options.

Discover our pipeline

Innovation by design

Our team shares a commitment to deliver on the promise of genetic medicine for people and families battling devastating diseases. Our clinical programs are assessing investigational compounds for Huntington’s disease, amyotrophic lateral sclerosis, frontotemporal dementia and Duchenne muscular dystrophy.

Our lead programs

Opportunities

Diversity of thought is not only welcomed here, it is expected.

Working at Wave

Patients and families

Learn about our commitment to patients and families and access information on our research programs.

Learn more

Opportunities

Diversity of thought is not only welcomed here, it is expected.

Working at Wave

Patients and families

Learn about our commitment to patients and families and access information on our research programs.

Learn more

About

  • Overview
  • History
  • Leadership
  • Commitment
  • Contact Us

Science

  • Overview
  • Platform
  • Collaborations
  • Manufacturing

Pipeline

  • Overview
  • Lead programs

Careers

  • Overview
  • Working at Wave
  • Opportunities
  • For patients/
  • For the scientific community/
  • For investors & media
  • Privacy Policy
  • Terms of use
  • Contact

© 2022 Wave Life Sciences. All Rights Reserved.

  • Wave Life Sciences Twitter
  • Wave Life Sciences LinkedIn
  • Privacy Policy
  • Terms of use
  • Contact

© 2022 Wave Life Sciences. All Rights Reserved.

Cancel Continue